Mersana Therapeutics, Inc.
MRSN
Revenue
2.75M
▼-13.61M▼-83.17%
3 Months ChangeAssets
112.47M
▼-32.19M▼-22.25%
3 Months ChangeLiabilities
143.34M
▼-10.83M▼-7.03%
3 Months ChangeFree Cash Flow
-29.33M
▲3.46M▲10.56%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-13
Form 10-Q
ID: 0001628280-24-036864
2024-08-13
Form 8-K
ID: 0001104659-24-088640
2024-06-11
Form 8-K
ID: 0001104659-24-070408
2024-05-09
Form 10-Q
ID: 0001628280-24-021985
2024-05-09
Form 8-K
ID: 0001104659-24-059104
2024-02-28
Form 8-K
ID: 0001104659-24-028715
2024-02-28
Form 8-K
ID: 0001104659-24-028467
2024-01-05
Form 8-K
ID: 0001104659-24-001627
2023-12-21
Form 8-K
ID: 0001104659-23-128209
2023-11-07
Form 10-Q
ID: 0001628280-23-037193